Literature DB >> 12193356

Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial.

Liedeke Koops1, Richard I Lindley.   

Abstract

OBJECTIVES: To determine whether consumer involvement would help to solve some of the ethical problems associated with research into thrombolysis for acute ischaemic stroke, with its inherent risk of fatal intracranial haemorrhage.
DESIGN: Quantitative and qualitative research. SETTING AND PARTICIPANTS: CONSULTATION PHASE: three meetings were held to discuss the planned research, and participants completed a questionnaire. QUALITATIVE WORK: focus group meetings explored the issues raised during the consultation phase. Design of information leaflets for patients and relatives: trial materials were drafted during the consultation phase and revised in the light of feedback from the focus group meetings and review by patients and carers on a stroke rehabilitation unit.
RESULTS: 54 people attended the consultation meetings. Four (9%) participants considered the risks of thrombolysis too great, but most (89%) were prepared to accept the treatment in a clinical trial. Nearly all would accept treatment if it was shown to be effective. Most (85%) would give their consent to enter the planned trial. The focus group meetings and feedback from patients and carers led to significant changes in the information leaflets. The revised trial materials were considered ethical by a national multicentre research ethics committee.
CONCLUSIONS: Consumers generally supported a planned trial, and their involvement helped to refine trial consent procedures and led to an ethically acceptable trial design.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2002        PMID: 12193356      PMCID: PMC119434          DOI: 10.1136/bmj.325.7361.415

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  11 in total

Review 1.  Lay perspectives: advantages for health research.

Authors:  V A Entwistle; M J Renfrew; S Yearley; J Forrester; T Lamont
Journal:  BMJ       Date:  1998-02-07

Review 2.  Thrombolytic treatment for acute ischaemic stroke: consent can be ethical.

Authors:  R I Lindley
Journal:  BMJ       Date:  1998-03-28

3.  Research involving critically ill subjects in emergency circumstances: new regulations, new challenges.

Authors:  A Wichman; A L Sandler
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

4.  Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey.

Authors:  B Hanley; A Truesdale; A King; D Elbourne; I Chalmers
Journal:  BMJ       Date:  2001-03-03

5.  New approach for recruitment into randomised controlled trials.

Authors:  M Baum
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

6.  A "ladyplan" for trial recruitment?--Everyone's business!

Authors:  H Thornton
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.

Authors:  B F Gage; A B Cardinalli; D K Owens
Journal:  Arch Intern Med       Date:  1996-09-09

9.  Patient preferences for stroke outcomes.

Authors:  N A Solomon; H A Glick; C J Russo; J Lee; K A Schulman
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

Review 10.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

View more
  34 in total

1.  Thrombolysis for acute ischaemic stroke. Trial participants need to be informed of uncertainty principle.

Authors:  Howard Mann
Journal:  BMJ       Date:  2002-12-07

2.  Breast cancer prevention.

Authors:  Kefah Mokbel
Journal:  Br J Gen Pract       Date:  2002-12       Impact factor: 5.386

3.  Participating in primary care research.

Authors:  Robert K McKinley; Mary Dixon-Woods; Hazel Thornton
Journal:  Br J Gen Pract       Date:  2002-12       Impact factor: 5.386

4.  'But is it a question worth asking?' A reflective case study describing how public involvement can lead to researchers' ideas being abandoned.

Authors:  Jonathan D Boote; Mary Dalgleish; Janet Freeman; Zena Jones; Marianne Miles; Helen Rodgers
Journal:  Health Expect       Date:  2012-05-31       Impact factor: 3.377

5.  Informing children and parents about research.

Authors:  A Dawson; S A Spencer
Journal:  Arch Dis Child       Date:  2005-03       Impact factor: 3.791

6.  A consumer network for haematological malignancies.

Authors:  Nicole Skoetz; Olaf Weingart; Andreas Engert
Journal:  Health Expect       Date:  2005-03       Impact factor: 3.377

7.  Qualitative data analysis for health services research: developing taxonomy, themes, and theory.

Authors:  Elizabeth H Bradley; Leslie A Curry; Kelly J Devers
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

8.  Understanding the experience of stroke: a mixed-method research agenda.

Authors:  Philippa Clarke
Journal:  Gerontologist       Date:  2009-04-22

9.  Supporting public involvement in research design and grant development: a case study of a public involvement award scheme managed by a National Institute for Health Research (NIHR) Research Design Service (RDS).

Authors:  Jonathan D Boote; Maureen Twiddy; Wendy Baird; Yvonne Birks; Clare Clarke; Daniel Beever
Journal:  Health Expect       Date:  2013-10-01       Impact factor: 3.377

Review 10.  The doctor's duty to the elderly patient in clinical trials.

Authors:  Antony Bayer; Mark Fish
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.